Lifetime Management of Aortic Valve Disease

The aim of the session is to consider optimal lifetime management of aortic valve disease in younger patients, including the options for multiple valve interventions, role and timing of surgery, valve choice, options for TAVR valve explant, coronary anatomy, anticoagulation.

This program has been made possible by an unrestricted educational grant from Medtronic.
The technologies being discussed may not be approved for use in your country.

Webinar dates are subject to change